Pravachol vs. Praluent

See how Pravachol and Praluent compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Pravachol is a low-cost daily tablet, while Praluent is an injection given every 2 to 4 weeks, so the two fit very different routines.

  • Praluent usually lowers LDL cholesterol more than Pravachol and is often added on top of a statin when diet and statin therapy alone are not enough.

  • Pravachol is an inexpensive generic with decades of use, while Praluent has no generic option and costs far more per month.

Pravachol vs. Praluent Drug Summary

Pravachol

Pravachol (pravastatin) is a statin that blocks an enzyme the liver uses to make cholesterol. It treats high LDL cholesterol, mixed dyslipidemia, and certain triglyceride disorders, and is taken as one tablet by mouth each day.

Praluent

Praluent (alirocumab) is a PCSK9 inhibitor that helps the liver clear more LDL cholesterol from the blood. It is used as an add-on to statin therapy for high cholesterol and to lower the risk of heart attack and stroke, given as a self-injection every 2 or 4 weeks.

Pravachol vs. Praluent Side Effects

Pravachol

Most common
musculoskeletal pain (up to 24.9%)
upper respiratory infection (up to 21.2%)
nausea/vomiting (up to 10.5%)
diarrhea (up to 6%)

Praluent

Most common
nasopharyngitis (up to 11.3%)
injection site reactions (up to 7.2%)
influenza (up to 5.7%)
urinary tract infection (up to 4.8%)

Pravachol vs. Praluent Dosage

Pravachol

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 40 mg once daily At the start
Maximum dose 80 mg once daily If needed
Dose changes 1 increase As tolerated

Praluent

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 75 mg every 2 weeks At the start
Maximum dose 300 mg every 4 weeks If needed
Dose changes 2 increases As tolerated

Pravachol vs. Praluent Indications

Pravachol

Pravachol is FDA-approved to lower LDL cholesterol and triglycerides and raise HDL in adults with high cholesterol or mixed dyslipidemia. It also reduces the risk of heart attack and stroke in people with or without existing heart disease, and treats familial hypercholesterolemia in children 8 and older.

  • Primary hyperlipidemia and mixed dyslipidemia

  • Heterozygous familial hypercholesterolemia (ages 8+)

  • Reduces risk of heart attack, stroke, and revascularization

  • High triglyceride levels (Type IV hyperlipidemia)

Praluent

Praluent is FDA-approved as an add-on to diet and maximally tolerated statin therapy to further lower LDL cholesterol in adults with primary hyperlipidemia. It also treats heterozygous familial hypercholesterolemia in adults and children 8 and older, and lowers the risk of heart attack, stroke, and hospitalization for unstable angina in people with existing cardiovascular disease.

  • Add-on LDL lowering with diet and a statin

  • Heterozygous familial hypercholesterolemia (ages 8+)

  • Reduces risk of heart attack and stroke after cardiovascular disease

  • Reduces hospitalization for unstable angina

Pravachol vs. Praluent Pros and Cons

Pravachol

Pravachol is a generic statin with decades of real-world safety data and broad insurance coverage. It works well for people who need moderate LDL lowering and prefer a daily pill over an injection.

Pros

  • Roughly $5 to $30 a month without insurance, depending on pharmacy

  • Taken by mouth, no injections or needles

  • Long track record dating back to 1991 approval

  • Widely covered by insurance and Medicare Part D

Cons

  • Lowers LDL less than PCSK9 inhibitors like Praluent

  • Must be taken every day without missing doses

  • Dose must be limited when combined with cyclosporine or clarithromycin

  • Muscle and joint pain are common side effects

Praluent

Praluent offers a stronger LDL-lowering option for people who still have high cholesterol despite statin therapy, or who cannot tolerate statins well. Its infrequent dosing schedule appeals to people who prefer fewer doses over daily pills, but it comes at a much higher cost.

Pros

  • Greater LDL reduction than statins alone

  • Only 26 injections a year at most, versus 365 daily pills

  • Proven to cut cardiovascular events after acute coronary syndrome

  • Option for patients who cannot tolerate statin side effects

Cons

  • Roughly $500 to $640 per month without insurance, before savings programs

  • Requires self-injection with a prefilled pen

  • No generic or biosimilar version currently available

  • Can cause injection site reactions and rare serious hypersensitivity reactions

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.